Patients will undergo an MRI to assess postoperative changes in tendon thickness, tendon quality and tear size, after implantation of the bioinductive implant. Researchers will also evaluate shoulder function. The study will be conducted with leading orthopedic and sports medicine surgeons across the United States, including Ted Schlegel, MD, of Vail, Colo.-based Steadman Clinic and Jeffrey Abrams, MD, of Princeton (N.J.) Orthopaedic Associates.
More articles on devices:
Spine device market report: 5 key concepts for future growth
Baxano Surgical looking beyond spinal fusion for future growth
DePuy Synthes inks commercial agreement with Blue Belt Technologies — 5 quick facts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
